CytoMed Therapeutics (GDTC) Earnings Date & Reports
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers... Show more
Get AI intraday signals
A.I. Advisor
published Earnings
GDTC is expected to report earnings to fall 66.67% to -3 cents per share on May 28
Q1'25
Est.
$-0.04
Q4'24
Missed
by $0.08
Q3'24
Est.
$-0.04
Q2'24
Beat
by $0.01
Q1'24
Est.
$-0.04
The last earnings report on May 05 showed earnings per share of -11 cents, missing the estimate of -3 cents. With 8.01K shares outstanding, the current market capitalization sits at 23.31M.